Flagship Pioneering

Flagship Pioneering

U.S-based venture capital firm funding U.S-startups in the life science industry.

Established in 2000, Flagship Pioneering (previously known as Flagship Ventures) is a venture capital firm founded by Noubar Afeyan and Edwin Kania. The firm primarily operates from Cambridge, Massachusetts although it also has an office in Ann Arbor, Michigan. The firm is currently managing a portfolio containing 37 companies and has sold off its shares in 121 companies. The firm’s most recent investment occurred in December 2018 for Indigo Agriculture, a biotechnology company specializing in plant microbiome agricultural services.

Funding

Flagship Pioneering focuses on funding startups that operate in the United States, especially in the Midwest region. The firm prefers to fund companies in the therapeutics, health technologies, life science, sustainability and clean technology business industries. It provides financing for companies at various stages of development, from incubation to growth stage. With its latest funding round raised in September 2017, the firm has managed to collect a total fund of $2.8 billion. During the September 2017 funding round, the firm amassed a total of $618 million in capital.

Timeline

May 27, 2020
Flagship Pioneering launches new agtech company to manage insect populations.

Funded Companies

Company
Description
Industry
Website
Location
Visterra

A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.

T2 Biosystems is a Lexington, Massachusetts-based company developing diagnostic products targeting sepsis and in vitro diagnostic products intended to target sepsis, hemostasis, bacteria, and lyme disease founded in 2006 by Robin Toft.

A biotechnology company making discoveries in genetic and metabolic diversity of the human microbiome into treatment and therapies for a wide range of diseases.

Indigo is an agricultural technology company utilizing natural microbiology and digital technologies to improve farmers' profitability, environmental sustainability and consumer health.

Foghorn Therapeutics is a Cambridge, Massachusetts-based company developing gene-specific therapies.

Avedro is a Waltham, Massachusetts-based company founded in 2007.

KSQ Therapeutics is a Cambridge, Massachusetts-based company in the pharmaceuticals industry founded in 2015.

Resolvyx Pharmaceuticals is a company developing small molecule therapeutics for the treatment of inflammatory diseases

Intio is a Broomfield, Colorado-based diagnostic tools company focused on diagnostics for oncology.

Tangent Medical Technologies is an Ann Arbor, Michigan-based healthcare company.

Inari is an insurance company founded by Frank Perkins.

24 Results
Results per page:
Page 1 of 1

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
Flagship Pioneering Fund VI, L.P.
500,000,000
September 14, 2017
5 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Adam J Koch

Employee

Avak Kahvejian

Employee

Bill Koteff

Employee

Brett Morrison

Employee

Brian Fiske

Employee

Bruce Miller

Investor

Chris Varma

Employee

Chuck Carelli

Chief Financial Officer

Chuck Eesley

Employee

David Berry

Employee

Deepak Jagannathan

Employee

Devesh Khanal

Employee

Edwin Kania

Co-Founder/Managing Partner

Emil Mamedov

Employee

Grace Brueckner

Employee

Harry Wilcox

Chief Operating Officer

Jacqueline Heard

Employee

Jaime Mateus

Employee

Jameson Rogers

Employee

Jason Patrick Schrum

Employee

Jernej Godec

Employee

Jerry Gupta

Employee

John Ballew

Employee

Kunle Demuren

Employee

Maneesh Gujrati

Employee

Page 1 of 2

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Agios

Alinea

Alvine Pharmaceutical

Avedro

Axcella

Bind Biosciences

News

Title
Author
Date
Publisher
Description
April 13, 2021
BioSpace
Repertoire Immune Medicines Secures $189M Financing to Advance Pipeline Programs and Discovery Platform Directed at Cellular Immune Targets - read this article along with other careers information, tips and advice on BioSpace
April 7, 2021
BioSpace
Tessera Therapeutics Strengthens Leadership Team to Advance 'Gene Writing' Platform & Accelerate Therapeutic Development - read this article along with other careers information, tips and advice on BioSpace
Nick Paul
March 31, 2021
FierceBiotech
Flagship Pioneering has named Michael Nally as CEO-partner. The venture capital shop has put the former Merck executive in charge of machine-learning-enabled drug discovery play Generate Biomedicines.
Connie Loizos
March 9, 2021
TechCrunch
The investment firm Flagship Pioneering has incubated a lot of life sciences companies since it was founded in 2000. In fact, while a general partner with Flagship Pioneering over the last 15 years, David Berry has started more than 30 companies, five of which trade publicly right now: Seres Therapeutics, Sensen Bio, Evelo Biosciences, T2 [...]
Nick Paul
February 11, 2021
FierceBiotech
Diego Miralles has joined Flagship Pioneering as CEO-partner. Flagship disclosed the appointment of Miralles, who will serve as CEO of its portfolio company Laronde, alongside news that it has hired ex-Rubius Therapeutics executive Andrew Oh as senior partner.
Allison DeAngelis
January 26, 2021
Business Insider
Sana Biotechnology raised hundreds of millions early on. Here are the investors and executives who stand to profit as it goes public.
Andrew Dunn and Allison DeAngelis
January 13, 2021
Business Insider
Sana has raised more than $700 million since its 2018 launch. Its IPO paperwork gave a rare look into the secretive biotech's finances and strategy.
Flagship Pioneering
January 13, 2021
www.prnewswire.com:443
/PRNewswire/ -- Flagship Pioneering, a life science platforms company, today announced the unveiling of Inzen Therapeutics. Flagship created Inzen in 2017 to...
Joanna Glasner
December 24, 2020
Crunchbase News
An interview with Noubar Afeyan, co-founder and chairman of Moderna, about the timeline of the company's remarkable "from outrageous, to obvious, to lifesaving" accomplishment.
Amirah Al Idrus
December 9, 2020
FierceBiotech
After at stint at Flagship Pioneering that was "one of the best experiences" in his career, Paul-Peter Tak, M.D., Ph.D., has a new gig. The former GlaxoSmithKline immunology chief takes over at Candel Therapeutics as the company gears up for a busy year.
Joanna Glasner
November 16, 2020
Crunchbase News
Moderna shook the world this morning with the announcement that its COVID-19 vaccine was 94.5 percent effective in Phase 3 trials.
Amirah Al Idrus
November 16, 2020
FierceBiotech
Luciano Rossetti is checking all the boxes. After nearly two decades in academic medicine and almost as long leading R&D teams at Merck KGaA and Merck & Co., he's jumping over to the venture world as Flagship Pioneering's first chief medical officer.
BioSpace
November 16, 2020
BioSpace
Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has strengthened its executive leadership team with the appointment of Luciano Rossetti, MD, as Chief Medical Officer (CMO) as well as the company's first Head of Research & Development (R&D) for its newly formed initiative Pioneering Medicines
Flagship Pioneering
November 16, 2020
www.prnewswire.com:443
/PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has strengthened its executive leadership team with...
BioSpace
September 24, 2020
BioSpace
Flagship Pioneering today announced the launch of Valo Health, LLC (Valo), a drug discovery technology company setting out to transform how oncology, neurodegenerative, and cardiovascular disease drugs are created, developed, and approved.
BioSpace
October 28, 2020
BioSpace
Flagship Pioneering today announced the unveiling of Senda Biosciences, a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans and coevolved nonhuman species.
Amirah Al Idrus
July 16, 2020
FierceBiotech
It's back to biotech for Guillaume Pfefer, and not a moment too soon. Having spent four years at GlaxoSmithKline ushering its shingles vaccine through approval and onto the market, he's now taking on the dual role of CEO-partner at Flagship Pioneering, joining the biotech builder's team while taking the helm at one of its startups, Kintai Therapeutics.
BioSpace
July 7, 2020
BioSpace
Tessera Therapeutics emerges from three years of stealth operations to pioneer Gene WritingTM as a new genome engineering technology and category of genetic medicine
Rowan Walrath
June 3, 2020
AmericanInno
It's an interesting time to be a person on the move.
Srividya Kalyanaraman
May 27, 2020
AmericanInno
The startup wants to modulate insect health by supplying essential nutrients and vitamins lacking in the insect's diet.
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.